Press Releases

GlobeNewswire, Inc.

Business Highlights: Delivered strong second quarter 2026 GAAP Net Income alongside continued market-leading Medicare Advantage membership growth Improved Full Year 2026 guidance across all metrics Increasing confidence for 2027 outlook, supported...

EIN Presswire

Experienced academic leader Gesine Gerhard, PhD, will guide the College’s newly unified academic home for the sciences, arts, humanities, and social sciences.

DVIDS - Georgia

MOODY AIR FORCE BASE, Ga. – Airmen from the 23d Medical Group Public Health Flight often operate behind the scenes, but during readiness or deployment surges, their impact is at the forefront.

Berkeley Lab - California

As Director of the Scientific Data Division at Lawrence Berkeley National Laboratory, Ana Kupresanin leads scientists and engineers who develop the methods, software, workflows, and infrastructure needed to make scientific data usable, reliable,...

Buncombe County - North Carolina

Buncombe County Public Health is seeking proposals from qualified vendors to design, develop, and implement a dashboard and scorecard system that supports comprehensive performance monitoring for Public Health programs.

GlobeNewswire, Inc.

– LOQTORZI® net revenue of $13.6 million in Q2 2026, up 15% over Q1 – – Clinical data continue to mature across programs with emerging evidence of activity with tagmokitug in head and neck cancer – – Projected October public disclosure of data...

GlobeNewswire, Inc.

PEMBROKE, Bermuda, Aug. 05, 2026 (GLOBE NEWSWIRE) -- AXIS Capital (NYSE: AXS) today announced it has agreed to acquire the renewal rights to the Excess Liability business of DUAL North America ("DUAL"), a leading specialty program administrator...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave”...

GlobeNewswire, Inc.

First participant dosed in QUELL-CV, a Phase 2 dose-ranging proof-of-concept trial of BGE-102 measuring inflammatory and cardiometabolic biomarkers; topline data anticipated in the second half of 2026 QUELL-DME, Phase 1b/2a proof-of-concept trial...

GlobeNewswire, Inc.

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to...

GlobeNewswire, Inc.

GAITHERSBURG, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biodefense company, today highlighted the increasing importance of biological threat preparedness as allied nations confront an evolving security...

GlobeNewswire, Inc.

Topline Safety, Tolerability and Immunogenicity Data from VAX-31 Adult Phase 3 OPUS-1 Trial Expected in Fourth Quarter of 2026; OPUS-2 and OPUS-3 Phase 3 Results Expected in First Half of 2027 Topline Safety, Tolerability and Immunogenicity Data...

GlobeNewswire, Inc.

2Q 2026 Total Revenue of $124.4 Million, Increasing 2% Year-over-Year 2Q 2026 ASCENIV Revenue of $102.9 Million, Increasing 24% Year-over-Year BIVIGAM Utilization Stabilized with Sequential Improvement in Demand and Revenue 2Q 2026 GAAP Net Income...

GlobeNewswire, Inc.

EDIT-401 on track for CTN submission this month with data update in Q1 2027 Recently presented pre-clinical data demonstrating ~90% or greater mean reduction in multiple atherogenic lipoproteins, including LDL-C, Lp(a) and ApoB with EDIT-401 in...

GlobeNewswire, Inc.

Continued strong ZORYVE® (roflumilast) net product revenue growth, with Q2 revenues of $129.9 million, +59% versus Q2 of 2025, and +23% versus Q1 of 2026, driven primarily by strong demand growth Company raising 2026 full-year net product sales...

GlobeNewswire, Inc.

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to...

GlobeNewswire, Inc.

First Quarter Financial Highlights: Increased Revenue by 30% Year-over-Year to a Record Level Exceeding $90 Million Reported Record Total Orders Above $130 Million Driven by the Utility-Sector Mining Developments Nearly Quadrupled Operating Cash...

GlobeNewswire, Inc.

RESTON, Va., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the second quarter and first half of fiscal...

GlobeNewswire, Inc.

Positive Interim Data Shared in 2Q 2026 from the MyPEAK™-1 and RIDGE™-1 Clinical Trials Each Demonstrated Meaningful Improvements in Key Disease Characteristics Additional Data Releases Plus Updates on Regulatory Discussions on Pivotal Trial Plans...

GlobeNewswire, Inc.

Q2 2026 Vafseo® (vadadustat) net product revenues grew to $21.3 million; more than 10,500 patients now on therapy Advancement of rare kidney disease pipeline continues with initiation of Phase 2 open-label basket trial evaluating ebribafusp for...